{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:29:47Z","timestamp":1747178987971,"version":"3.40.5"},"reference-count":84,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2022,8,3]]},"DOI":"10.1080\/14760584.2022.2078311","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T16:12:15Z","timestamp":1652458335000},"page":"1087-1095","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Safety profile of COVID-19 vaccines, preventive strategies, and patient management"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0679-3323","authenticated-orcid":false,"given":"M. Mukhyaprana","family":"Prabhu","sequence":"first","affiliation":[{"name":"Department of General Medicine, KMC Manipal, MAHE (deemed to be University), India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-3940","authenticated-orcid":false,"given":"Subish","family":"Palaian","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5247-6356","authenticated-orcid":false,"given":"Mukhtar","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"cit0001","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard. 2021 [Cited 2021 1 Jun]. Available from: https:\/\/covid19.who.int\/."},{"key":"cit0002","unstructured":"Bergman SJ, Cennimo DJ, Miller MM, et al. COVID-19 treatment: investigational drugs and other therapies. Medscape; 2021 [Cited 2021 May 31]. Available from: https:\/\/emedicine.medscape.com\/article\/2500116-overview"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/s42600-020-00116-1"},{"key":"cit0004","unstructured":"US Food and Drug Administration. Emergency use authorization (EUA) 2021[Cited 2021 May 30]. Available from: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-legal-regulatory-and-policy-framework\/emergency-use-authorization#vaccines"},{"key":"cit0005","unstructured":"World Health Organization. Status of COVID-19 vaccines within WHO EUL\/PQ evaluation process. 2021 [Cited 2021 May 30]. Available from: https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/documents\/Status_COVID_VAX_18May2021.pdf."},{"key":"cit0006","unstructured":"Craven J. COVID-19 vaccine tracker. regulatory affairs professional society (raps) publication. Available from 2021 Nov 12: https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker"},{"key":"cit0007","unstructured":"World Health Organization. More than 150 countries engaged in COVID-19 vaccine global access facility. 2020 [Cited 2021 Jun 2]. Available from: https:\/\/www.who.int\/news\/item\/15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00108-0"},{"key":"cit0009","unstructured":"Eniola K, Sykes J. Four reasons for COVID-19 vaccine hesitancy among health care workers, and ways to counter them. Fam Pract Manag.[Cited 2021 May 29]. Available from https:\/\/www.aafp.org\/journals\/fpm\/blogs\/inpractice\/entry\/countering_vaccine_hesitancy.html."},{"key":"cit0010","unstructured":"National Records of Scotland (NRS). Covid: three deaths in Scotland linked to vaccine. BBC. 2021 [Cited 2021 Jun 2]. Available from: https:\/\/www.bbc.com\/news\/uk-scotland-57173286"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1372"},{"journal-title":"Pew Res Center","year":"2020","author":"Tyson A","key":"cit0012"},{"key":"cit0013","unstructured":"Inacio P. Quick approval given COVID vaccines raise concerns, rare disease patients say. Sickle Cell Disease News 2021 [Cited 2021 Jun 7]. Available from: https:\/\/sicklecellanemianews.com\/2021\/04\/23\/quick-approval-given-covid-vaccines-raise-concerns-rare-disease-patients-say\/"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.paid.2020.110590"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-021-00968-z"},{"key":"cit0016","unstructured":"Beusekom MV. Data reveal fewer real-world COVID vaccine side effects. Center for infectious Disease Research and Policy. 2021 [Cited 2021 June 7]. Available from: https:\/\/www.cidrap.umn.edu\/news-perspective\/2021\/04\/data-reveal-fewer-real-world-covid-vaccine-side-effects"},{"key":"cit0017","unstructured":"Health and Safety Executive. Safety update: vaxzevria (COVID-19 vaccine AstraZeneca) and COVID-19 vaccine Janssen 2021 [Cited 2021 Jun 7]. Available from.https:\/\/www.hse.ie\/eng\/health\/immunisation\/hcpinfo\/covid19vaccineinfo4hps\/astrazeneca\/azqnda.pdf"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110475"},{"issue":"11","key":"cit0019","first-page":"996","volume":"138","author":"Paulsen F","year":"2021","journal-title":"Blood"},{"issue":"4","key":"cit0020","first-page":"293","volume":"138","author":"Arepally GM","year":"2021","journal-title":"Blood J Am Soc Hematol"},{"key":"cit0021","unstructured":"Center for Disease Control and Prevention-Wonder. The vaccine adverse event reporting system (VAERS) 2021 [Cited 2021 May 26]. Available from: http:\/\/wonder.cdc.gov\/vaers.html"},{"key":"cit0022","unstructured":"US Food and Drug Administration. Janssen COVID-19 vaccine EUA fact sheet for healthcare providers 2021 [Cited 2021 May 26]. Available from: https:\/\/www.fda.gov\/media\/146304\/download"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1967"},{"key":"cit0024","unstructured":"COVID-19 Vaccine (adenovirus vector). Lexicomp online database [database on the internet]. Hudson (OH): Lexicomp Inc. publication year 2021; cited Nov 24. Available from. http:\/\/online.lexi.com"},{"issue":"6","key":"cit0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.nrl.2021.05.001","volume":"36","author":"Garc\u0131a-Azor\u0131n D","year":"2021","journal-title":"Neurolog\u0131a"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.04.006"},{"key":"cit0027","unstructured":"US Food and Drug Authority. Moderna COVID-19 Vaccine EUA fact sheet for health care providers 2021 [Cited 2021 May 26]. Available from: https:\/\/www.fda.gov\/media\/144637\/download"},{"key":"cit0028","unstructured":"US Food and Drug Authority. Pfizer-BioNTech COVID-19 vaccine EUA fact sheet for healthcare providers 2021 [Cited 2021 May 26]. Available from: https:\/\/www.fda.gov\/media\/144413\/download"},{"key":"cit0029","unstructured":"AstraZeneca. COVID-19 AstraZeneca vaccine analysis print 2021 [Cited 2021 June 7]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/990932\/COVID-19_AstraZeneca_Vaccine_Analysis_Print_26.05.2021.pdf"},{"key":"cit0030","unstructured":"Feuerstein A. Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says. Stat news. 2020 [Cited 2021 Jun 7]. Available from: https:\/\/www.statnews.com\/2020\/09\/09\/astrazeneca-covid19-vaccine-trial-hold-patient-report\/"},{"key":"cit0031","unstructured":"Package leaflet: information for the user interim authorization COVID-19 Vaccine Moderna dispersion for injection: moderna biotech 2021 [Cited 2021 Jun 2]. Available from https:\/\/www.hsa.gov.sg\/docs\/default-source\/hprg-tpb\/guidances\/covid-19-vaccine-moderna-sg-pil.pdf"},{"journal-title":"Medical News Today","year":"2021","author":"Jeong M","key":"cit0032"},{"key":"cit0033","unstructured":"US Food and Drug Authority. Fact sheet for recipients and caregivers 2021 [Cited 2021 Jun 7]. Available from: https:\/\/www.fda.gov\/media\/144414\/download"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3976"},{"journal-title":"Health","year":"2021","author":"Miller K","key":"cit0035"},{"key":"cit0036","unstructured":"Heart inflammation probed as possible rare Covid vaccine side effect in teens, young adults. The Economic Times. 2021 [Cited 2021 Jun 5]. Available from: https:\/\/economictimes.indiatimes.com\/magazines\/panache\/heart-inflammation-probed-as-possible-rare-covid-vaccine-side-effect-in-teens-young-adults\/articleshow\/83228841.cms"},{"key":"cit0037","unstructured":"Mandavilli ACDC. Is investigating a heart problem in a few young vaccine recipients? The New York Times. 2021 [Cited 2021 Jun 4]. Available from:https:\/\/www.nytimes.com\/2021\/05\/22\/health\/cdc-heart-teens-vaccination.html"},{"key":"cit0038","unstructured":"Buntz B. Tinnitus reports grow amid COVID-19 vaccinations.drug discovery and development 2021 [Cited 2021 May 25]. Available from: https:\/\/www.drugdiscoverytrends.com\/tinnitus-reports-grow-amid-covid-19-vaccinations\/"},{"key":"cit0039","unstructured":"Jeong M. Moderna COVID-19 vaccine: what to know about side effects. Medical News Today. 2021 [Cited 2021 May 19]. Available from: https:\/\/www.medicalnewstoday.com\/articles\/moderna-covid-19-vaccine-what-to-know-about-side-effects"},{"key":"cit0040","unstructured":"Schraer R. Covid vaccine: sore arm and headache most common side effects. BBC. 2021 [Cited 2021 May 5]. Available from: https:\/\/www.bbc.com\/news\/health-56901356"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7004e1"},{"key":"cit0042","unstructured":"Launder M. Fatigue and headache \u2018most common Covid vaccine side effects\u2019 Pulse 2021 Cited 2021 May 21]. Available from https:\/\/www.pulsetoday.co.uk\/news\/clinical-areas\/pain\/fatigue-and-headache-most-common-covid-vaccine-side-effects\/"},{"key":"cit0043","unstructured":"Martin V. Ask the expert: the COVID-19 vaccination and headache. National Headache Foundation. 2021 [Cited 2021 May 19]. Available from: https:\/\/headaches.org\/2021\/03\/24\/ask-the-expert-covid-19-vaccination-and-headache\/"},{"key":"cit0044","unstructured":"COVID-19 vaccination guidelines for clinical immunology\/allergy specialists. ASCIA. 2021 Cited 2021 Nov 17]. Available from https:\/\/www.allergy.org.au\/hp\/papers\/guide-covid-19-vaccination"},{"key":"cit0045","unstructured":"What are the side effects of the Pfizer vaccine? Open Access Government. 2021 [Cited 2021 Jun 19]. Available from: https:\/\/www.openaccessgovernment.org\/what-are-the-side-effects-of-the-pfizer-vaccine\/104380\/"},{"key":"cit0046","unstructured":"Bussel JB, Connors JM, Cines DB. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia. version 1.2. American Society of Hematology. 2021 [Cited 2021 May 29]. Available from: https:\/\/www.hematology.org\/covid-19\/vaccine-induced-immune-thrombotic-thrombocytopenia"},{"key":"cit0047","unstructured":"Shapiro N. Study looks at link between Covid-19 vaccine and sudden hearing loss. Forbes 2021. https:\/\/www.forbes.com\/sites\/ninashapiro\/2021\/05\/23\/study-looks-at-link-between-covid-19-vaccine-and-sudden-hearing-loss\/?sh=7ce744e75a81. Cited 2021 May 25]. Available from"},{"issue":"2","key":"cit0048","first-page":"46","volume":"70","year":"2021","journal-title":"MMWR Early Release"},{"key":"cit0049","unstructured":"Walker MACIP. No rise in anaphylaxis rates after COVID Vax. Medpage Today. 2021 Cited 2021 Nov 17]. Available from https:\/\/www.medpagetoday.com\/infectiousdisease\/covid19\/90919"},{"issue":"4","key":"cit0050","first-page":"125","volume":"70","year":"2021","journal-title":"MMWR Early Release"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2035343"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0667"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101061"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109908"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.09.012"},{"key":"cit0057","unstructured":"ACAAI updates to guidance on risk of allergic reactions to Covid-19 vaccines. American College of Allergy, Asthma & Immunology. 2021 [Cited 2021 May 11]. Available from: https:\/\/acaai.org\/news\/acaai-updates-guidance-risk-allergic-reactions-covid-19-vaccines"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.029"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-016-0172-7"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.083"},{"issue":"7","key":"cit0061","first-page":"1325","volume":"68","author":"Tang AW","year":"2003","journal-title":"Am Fam Physician"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1111\/all.14838"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1055\/a-1469-7481"},{"issue":"6","key":"cit0064","first-page":"719","volume":"83","author":"Sharma S","year":"2011","journal-title":"Am Fam Physician"},{"issue":"2","key":"cit0065","first-page":"221","volume":"13","author":"Squires JE","year":"2015","journal-title":"Blood Transfus"},{"key":"cit0066","unstructured":"Warkentin TE, Cuker A. COVID-19: vaccine-induced immune thrombotic thrombocytopenia (VITT). Uptodate. 2021 Cited 2021 Nov 17]. Available from https:\/\/www.uptodate.com\/contents\/covid-19-vaccine-induced-immune-thrombotic-thrombocytopenia-vitt#H364190061"},{"key":"cit0067","unstructured":"Su JR. Myopericarditis following COVID-19 vaccination: updates from the vaccine adverse event reporting system (VAERS).2021 CDC [Cited 2021 Nov 17] Available from https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-08-30\/03-COVID-Su-508.pdf"},{"key":"cit0068","unstructured":"COVID-19 vaccines while pregnant or breastfeeding. CDC. 2021 [Cited 2021 May 23]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html"},{"journal-title":"Up to Date","year":"2021","author":"Berghella V","key":"cit0069"},{"key":"cit0070","unstructured":"Information for pediatric healthcare providers. CDC. 2020 [Cited 2021 Jun 9]. Available from:https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/pediatric-hcp.html"},{"key":"cit0071","unstructured":"Pfizer-BioNTech announce positive topline results of pivotal COVID-19 vaccine study in adolescents. Pfizer. 2021 [Cited 2021 May 7]. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-biontech-announce-positive-topline-results-pivotal"},{"key":"cit0072","unstructured":"Ghosh P. When to take Covid-19 vaccine after recovery? wait for 3 months, says centre. Hindustan Times. 2021 [Cited 2021 May 24]. Available from: https:\/\/www.hindustantimes.com\/india-news\/vaccination-3-months-after-recovery-from-covid-19-says-health-ministry-101621421679394.html"},{"key":"cit0073","unstructured":"Frequently asked questions about COVID-19 vaccination. CDC. 2021 [Cited 2021 Jun 19]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/faq.html"},{"key":"cit0074","unstructured":"COVID-19 vaccine reported allergic reactions. Allergy and Asthma Network. 2021 [Cited 2021 May 21]. Available from: https:\/\/allergyasthmanetwork.org\/news\/statement-on-covid-vaccine\/"},{"key":"cit0075","unstructured":"Erskine D. Using COVID-19 vaccines in patients with anticoagulation and bleeding disorders. Specialist Pharmacy Service. 2021 [Cited 2021 Jun 11]. Available from: https:\/\/www.sps.nhs.uk\/articles\/using-covid-19-vaccines-in-patients-with-anticoagulation-and-bleeding-disorders\/"},{"key":"cit0076","unstructured":"Guidance on treatment for rare blood clots and low platelets related to COVID-19 vaccine. Newsroom. 2021 [Cited 2021 May 9]. Available from: https:\/\/newsroom.heart.org\/news\/guidance-on-treatment-for-rare-blood-clots-and-low-platelets-related-to-covid-19-vaccine"},{"key":"cit0077","unstructured":"People with certain medical conditions. CDC. 2021 [Cited 2021 May 27]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656362"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00077-1"},{"key":"cit0080","first-page":"101158","volume":"41","author":"Rahav G","year":"2021","journal-title":"E Clinical Medicine"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.07.031"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2108861"},{"key":"cit0083","unstructured":"COVID-19 vaccine safety surveillance. [Cited 2021 Nov 17]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/covid-19-vaccine-safety-surveillance"},{"key":"cit0084","unstructured":"Law B. SO2-D2.1.2 priority list of COVID-19 adverse events of special interest: quarterly update December 2020. SPEAC. 2020 Cited 2021 Nov 17]. Available from https:\/\/brightoncollaboration.us\/wp-content\/uploads\/2021\/01\/SO2_D2.1.2_V1.2_COVID-19_AESI-update-23Dec2020-review_final.pdf"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2022.2078311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T10:13:55Z","timestamp":1676542435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2022.2078311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,3]]}},"alternative-id":["10.1080\/14760584.2022.2078311"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2022.2078311","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"type":"print","value":"1476-0584"},{"type":"electronic","value":"1744-8395"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}